Nabilone, a CB1 agonist, for managing multiple sclerosis symptoms
By Dr Filipa Serrazina, Neurology Resident, Barts Health NHS Trust
Project poster
Project write up
More MS Academy Medication Projects
Experience with Cladribine in RRMS patients at Lancashire Teaching Hospitals NHS Foundation Trust
By Dr Suhaib Mohammed, specialty registrar neurology, Lancashire Teaching Hospitals NHS Foundation Trust
Evaluating the need for routine testing and antibiotic use in patients receiving Ocrelizumab
By Evaluating the need of routine testing and antibiotic use in patients receiving Ocrelizumab
Adherence to Shared Care Protocols for Sativex in Managing MS-Related Spasticity: A Concordance Audit Across Primary and Secondary Care
By Dr Arunachalam Soma, Dr Jordan Russell & Dr Kate Petheram
Encouraging excellence, developing leaders, inspiring change
MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.